ePrescribing Market

Market Leader - ePrescribing Market

The global ePrescribing market size is projected to reach USD 3.3 billion by 2025 from USD 1.2 billion in 2020, at a CAGR of 23.3%. In 2019, Cerner Corporation (US),  EPIC Systems Corporation (US), and Allscripts (US) dominated the global ePrescribing  industry.

Some of the other prominent players operating in the ePresciribing market are Prominent players in the global e-prescribing market are NextGen Healthcare (US), athenahealth, Inc. (US), RelayHealth, LLC (US), Henry Schein, Inc. (US), GE Healthcare (US), Computer Programs and Systems Inc. (US), DrFirst, Inc. (US), Surescripts-RxHub, LLC (US), and Medical Information Technology, Inc. (US). Major players in this market pursued the strategies of agreements, collaborations, and partnerships as their growth strategies.

To know about the assumptions considered for the study download the pdf brochure

Cerner Corpration (US)  is a leading provider of e-prescribing solutions to hospitals, pharmacies, and officebased physicians. Cerner mainly focuses on inorganic growth strategies such as collaborations, agreements, and partnerships. In line with this strategy, Cerner collaborated with Mayo Clinic and OxfordClinic in London to help them leverage their Millennium EHR platform in the UK. It also signed agreements with other countries in Europe, such as Sweden, to help them leverage its healthcare IT solutions. The company also focuses on expanding its business globally in order to strengthen its position in the eprescribing market, particularly in the high-growth Asia Pacific and Latin American regions. Currently, Europe and North America account for about 90% of the company’s e-prescribing business.

Epic Systems Corporation (US) accounted for the second-largest share of ePrescribing market in 2019. The company specializes in interoperable solutions and mainly focuses on the needs of mediumsized and large hospitals and integrated healthcare organizations. The company has adopted various inorganic strategies such as collaborations and partnerships, which has helped it to enhance its product offerings. Additionally, the company’s integrated telehealth portals have helped hospitals, especially during the COVID-19 pandemic, where telehealth consultations have risen to close to 50% of the total visits. As telemedicine is closely followed with medical prescriptions via e-prescribing solutions, the company is
expected to witness increased use of the functionality during the pandemic.

Allscripts Healthcare Solutions, Inc.(US) provides innovative clinical software and services that deliver significant benefits to patients and healthcare professionals. The company focuses on R&D activities to enhance its service offerings. In 2019, the company invested USD 254.5 million—about 14% of its total revenue—on R&D. In November 2018, Allscripts announced Veradigm as the new brand for its life science division and now provides e-prescription modules to healthcare providers under the Veradigm brand. Another factor contributing to the major share of the company is its agreement with CoverMyMeds for the Allscripts electronic prior authorization (ePA) software to enable prescription providers to quickly authorize prescriptions electronically. CoverMyMeds is the largest ePA platform in the US and includes a network of
60,000 pharmacies and 700,000 providers in the country.

Related Reports:

ePrescribing Market by Product & Services (Solution (Integrated, Standalone), Services(Implementation, Network)),by Delivery Mode (Web & Cloud based, On premise) End User (Hospitals, Physician Offices, Pharmacies), COVID-19 Impact-Global Forecast to 2025

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
HIT 1370
RI Published ON
8/12/2020
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the ePrescribing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved